Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the study history. This is an update to the page’s version history rather than to the trial data or content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedVersion history shows a new revision v3.4.2 added and revision v3.4.1 removed, reflecting administrative updates to the record rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe history table shows a new revision entry (v3.4.1) and removal of v3.4.0 as part of administrative versioning updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedA new revision entry (v3.3.4) was added to the record history, and the previous revision (v3.3.3) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a new revision entry v3.3.3 to the Study Record Versions history; removed the items HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.2%

- Check112 days agoChange DetectedThe page history shows an added Revision: v3.3.2 and removal of Revision: v3.2.0, which are metadata updates to the record history and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.